Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
10822154
ABSTRACT:
A new crystalline Form III of moxifloxacin monohydrochloride and processes for making the crystalline form as well as compositions, pharmaceutical compositions, and methods utilizing the crystalline form are described.
REFERENCES:
patent: 5849752 (1998-12-01), Grunenberg et al.
Eswaraiah Sajja
Kumar Rapolu Rajesh
Raju Vetukuri Venkata Naga Kali Vara Prasada
Ravindra Vedantham
Reddy Manne Satyanarayana
Cepeda Milagros A.
Franks Robert A.
Reddy's Laboratories Limited
Reddy's Laboratories, Inc.
Seaman D. Margaret
LandOfFree
Crystalline form III of anhydrous moxifloxacin hydrochloride... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form III of anhydrous moxifloxacin hydrochloride..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form III of anhydrous moxifloxacin hydrochloride... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3885345